Biotechnology and Life Sciences

Rensselaer Researcher To Develop Drug for Rare Childhood Disease That Leads to Blindness

Rensselaer Polytechnic Institute’s Christopher Cioffi, Ph.D., Thomas and Constance D’Ambra Professor in Organic Chemistry, has received a $2.5 million grant from the National Institutes of Health, along with Konstantin Petrukhin of Columbia University and Gennadiy Moiseyev of Wake Forest University. The grant will enable the team to design a drug to treat Stargardt disease, a rare retinal disorder.

RPI and Albany Medical College Researchers Awarded $3.3 Million To Improve Breast Cancer Treatment Using Artificial Intelligence

Researchers from Rensselaer Polytechnic Institute (RPI) and Albany Medical College were awarded a $3.3 million grant over five years by the National Cancer Institute to use artificial intelligence (AI) to improve targeted drug therapy in HER2-positive breast cancer treatment. HER2-positive breast cancer tends to grow and spread quickly, but targeted treatments improve outcomes.

Steven Cramer Elected to the National Academy of Engineering

Steven Cramer, the William Weightman Walker Professor of Polymer Engineering and a professor in the Isermann Department of Chemical and Biological Engineering at Rensselaer Polytechnic Institute (RPI), has been elected to the National Academy of Engineering for “scientific and technological advances leading to new chromatographic materials, processes, and predictive tools for the purification of biopharmaceuticals.”

Rensselaer Researcher Proves a Link Between Alzheimer’s Disease, Osteoporosis, and Diabetes

In an article published in the Journal of Bone and Mineral Research, researchers at Rensselaer Polytechnic Institute (RPI) Dr. Deepak Vashishth and Joan Llabre, a Ph.D. student in the Department of Biomedical Engineering, presented evidence of a link between Alzheimer’s, osteoporosis, and diabetes. While recent evidence showed loss of bone mineral density with Alzheimer’s disease, this is the first study to demonstrate the effects of the Alzheimer’s disease phenotype on bone quality and link changes in bone and amyloid formation in the brain.

Back to top